Veracyte (VCYT) Gross Profit (2012 - 2026)

Veracyte (VCYT) has 15 years of Gross Profit data on file, last reported at $101.2 million in Q1 2026.

• Quarterly Gross Profit rose 27.23% year-over-year to $101.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $384.2 million (up 21.89% YoY) and the FY2025 annual result came in at $362.5 million, up 21.6% from the prior year.
• Gross Profit eased to $101.2 million in Q1 2026 per VCYT's latest filing, from $102.0 million in the prior quarter.
• The five-year high for Gross Profit was $102.0 million in Q4 2025, with the low at $44.0 million in Q1 2022.
• Average Gross Profit over 5 years is $70.3 million, with a median of $64.8 million recorded in 2023.
• Year-over-year, Gross Profit jumped 115.75% in 2022 and advanced 10.97% in 2024.
• Veracyte's Gross Profit stood at $56.2 million in 2022, then rose by 15.34% to $64.8 million in 2023, then advanced by 21.56% to $78.8 million in 2024, then advanced by 29.48% to $102.0 million in 2025, then slipped by 0.8% to $101.2 million in 2026.
• Business Quant data shows VCYT's Gross Profit at $101.2 million in Q1 2026, $102.0 million in Q4 2025, and $91.3 million in Q3 2025.